A Study of TMC435350 Administered With or Without Standard of Care Therapy in Participants With Genotype 1 Hepatitis C Virus Infection
Clinical trial NCT00561353 · COMPLETED
Trial details
- NCT number
- NCT00561353
- Sponsor
- Tibotec Pharmaceuticals, Ireland
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-01-01
- Primary completion
- 2008-12-01
- Enrollment
- 121
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.